Current Pharmacogenomics and Personalized Medicine

Formerly Current Pharmacogenomics


Ramón Cacabelos
International Center of Neuroscience and Genomic Medicine
EuroEspes Biomedical Research Center


Become EABM
Become Reviewer

Most Cited Article

Herbal Drug Discovery: Challenges and Perspectives

Volume:16   Issue:1
Pp: 63-68
Subramani Parasuraman*
DOI: 10.2174/1875692116666180419153313

Drug Abuse Treatment through Gene Manipulation Using Nanomedicine open access plus

Volume:16   Issue:3
Pp: 182-191
Firoozeh Alavian*
DOI: 10.2174/1875692117666181207120751

Oxidative Stress as a Key Signaling Pathway in Placental Angiogenesis Changes in Preeclampsia: Updates in Pathogenesis, Novel Biomarkers and Therapeutics open access plus

Volume:16   Issue:3
Pp: 167-181
Enoch Odame Anto, Peter Roberts, Cornelius Archer Turpin and Wei Wang*
DOI: 10.2174/1875692117666181207120011

Molecular Mechanism of Metformin Associated Lactic Acidosis (MALA)- an In Silico Exploration open access plus

Volume:16   Issue:3
Pp: 199-209
Siddiqur Rahman, Tamim Ahsan, Riajul Hossain, Tasnim Ahmed and Abu Ashfaqur Sajib*
DOI: 10.2174/1875692117666181207121639

Association between Paraoxonase 1(PON1) Gene Polymorphisms and PON1 Enzyme Activity in Indian Patients with Coronary Artery Disease (CAD) open access plus

Volume:16   Issue:3
Pp: 219-229
Renuka Munshi*, Falguni Panchal, Ajay Chaurasia and Girish Rajadhyaksha
DOI: 10.2174/1875692117666181227112119

Individualized Cancer Therapy, Future Approaches open access plus

Volume:16   Issue:2
Pp: 156-163
Da-Yong Lu*, Ting-Ren Lu, Bin Xu, Jin-Yu Che, Ying Shen and Nagendra Sastry Yarla
DOI: 10.2174/1875692116666180821095434

Validation of Traditional Medicinal Practices through Modern Scientific Tools and Techniques promotion: free to download

Volume:16   Issue:1
Pp: 3-3
Vijay Kothari
DOI: 10.2174/187569211601180716105632

The Gut Microbiota in Cardiovascular Diseases: From Biomarkers and Potential Targets to Personalized Interventions

Volume:16   Issue:1
Pp: 75-85
Yaroslav I. Ashikhmin, Abram L. Syrkin, Andrey A. Zamyatnin Jr.*, Yong Zhang and Philipp Yu. Kopylov*
DOI: 10.2174/1875692116666180511170329

Mutation Analysis of ABL1 Gene and its Relation to the Achievement of Major Molecular Response in Indonesian Chronic Myeloid Leukemia Patients open access plus

Volume:17   Issue:1
Pp: 48-54
Reni Widyastuti, Melva Louisa, Ikhwan Rinaldi*, Riki Nova , Instiaty Instiaty and Rizky Priambodo
DOI: 10.2174/1875692117666190925115852

Genetic Polymorphisms of CYP2D6: Prevalence in Healthy Kurds open access plus

Volume:17   Issue:1
Pp: 40-47
Muslih Abdulkarim Ibrahim*, Zalina Zahari*, Nurfadhlina Musa and Khoo Boon Yin
DOI: 10.2174/1875692117666190416145331

HLA-B27 is a Risk Factor for Rheumatoid Arthritis: Suggestion for an Evidence-based Update open access plus

Volume:17   Issue:1
Pp: 7-10
Seyyed Amir Yasin Ahmadi, Reza Mohammadrezaei-Khorramabadi, Saber Abbaszadeh, Jafar Rezaian and Farhad Shahsavar*
DOI: 10.2174/1875692117666190408113012

Peculiaritie of Distribution of Polymorphic Variants of IL1Β Gene in Patients with Atherosclerosis and Metabolic Syndrome open access plus

Volume:17   Issue:1
Pp: 32-39
Saranchina Y. Vladimirovna*, Rossova N. Aleksandrovna, Khanarin N. Vladimirovich, Kilina O. Yur'evna, Dutova S. Vyacheslavovna and Kulakova T. Sergeevna
DOI: 10.2174/1875692117666190416150346

Validation of Traditional Medicinal Practices Through Modern Scientific Approach: A Case for Reconsideration promotion: free to download

Volume:17   Issue:1
Pp: 11-13
Vijay Kothari*
DOI: 10.2174/1875692118666191223155350

Differences in MDR1 (C3435T), CYP2D6, and CYP1A2 Genotype Frequencies between Patients with Treatment Failure to Antipsychotics and Healthy Russian Population open access plus

Volume:17   Issue:1
Pp: 55-63
Tatiana Zhiganova *, Radkova Eugenia, Sergeeva Tatiana and Volovnikova Viktoriia
DOI: 10.2174/1875692117666190724141831

High Frequency of the Opioid Receptor µ-1 (OPRM1) A118G Polymorphism, an Opioid Drug Therapy Related Gene, in the Indonesian Population open access plus

Volume:17   Issue:1
Pp: 64-69
Alvina Arum Puspitasari, Zullies Ikawati*, Sri Swasthikawati and Anindya Rahmawati
DOI: 10.2174/1875692117666191211154755

Pharmacokinetics and Systems Pharmacology of Anti-CD47 Macrophage Immune Checkpoint Inhibitor Hu5F9-G4 open access plus

Volume:17   Issue:1
Pp: 14-24
Adarsh Mishra, Ishant Kataria and Sujit Nair*
DOI: 10.2174/1875692117666190820105134

Towards a Mature Discipline of Pharmacogenomics: Epistemological Reflections promotion: free to download

Volume:17   Issue:1
Pp: 3-6
Ramón Cacabelos
DOI: 10.2174/187569211701200318091701

Metabolomics-based Approach to Pharmacotherapy Personalization: Advantages and Limitations open access plus

Volume:16   Issue:3
Pp: 192-198
Dmitry L. Maslov*, Elena E. Balashova, Oxana P. Trifonova and Petr G. Lokhov
DOI: 10.2174/1875692116666181008144905

Computational Studies of Molecular Targets Regarding the Adverse Effects of Isoniazid Drug for Tuberculosis open access plus

Volume:16   Issue:3
Pp: 210-218
Nachimuthu Mohanasundaram and Talluri Sekhar*
DOI: 10.2174/1875692116666181108145230

Current Clinical Application and Response Prediction Biomarkers of PARP Inhibitors open access plus

Volume:16   Issue:2
Pp: 108-117
Wei-Hua Shao, Lei-Yun Wang and Ji-Ye Yin*
DOI: 10.2174/1875692116666180821152601